Reducing the Risk of Relapse in Patients With Pancreatic Cancer

February 24, 2014
Robert L. Fine, MD

Special Reports, Gastrointestinal Cancers (Issue 1), Volume 1, Issue 1

Robert L. Fine, MD, from Columbia University, discusses reducing the risk of relapse in patients with pancreatic cancer.

Robert L. Fine, MD, associate professor of medicine, Herbert Irving, director, Experimental Therapeutics, medical oncology director, Pancreas Center, Columbia University, discusses reducing the risk of relapse in patients with pancreatic cancer.

Read more abouta hedgehog pathway inhibitor for the treatment of advanced pancreatic cancer > >